GovChime
AWARDPURCHASE ORDEROther than small business

Purchase order 75N95020P00674RETROGENIX LIMITED

Overview

Award facts

Net obligations
$7K
$7,000of $7K potential value
Period of performance
Sep 23, 2020 to Mar 22, 2021
Ended
Modifications
1
Latest action Sep 15, 2025
Contract type
Purchase order
PIID 75N95020P00674

Description of requirement

FY20.SMALL MOLECULE TARGET DECONVOLUTION VIA RADIOLABELED SMALL MOLECULE-CELLULAR PROTEIN INTERACTION. POP: 9/23/2020 - 3/22/2021. BASE AWARD

Dates and value

Award date
Signed on Sep 22, 2020
Potential end of performance
Mar 21, 2021
Current value
$7,000Base and exercised options
Potential value (if all options are exercised)
$7,000

Obligations by fiscal year of action

  • FY2025: -$48,800 (de-obligation)
  • FY2020: $55,800

Total across 2 fiscal years: $7,000

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 15, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationSTOCKPORT, GBR
UEIXCWDH19PM8G7
CAGE codeU0TC0
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companyRETROGENIX LIMITED

Business types and certifications

For-profit organizationTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded from
National institute on drug abuse (0893)Program activities075-0893Federal accounts (agency financial reports)

Place of performance

Place of performance
United Kingdom

Classification and competition

Classification

Competition

Extent competed
Not competedC
Reason not competed
Only one source-other (FAR 6.302-1 other)ONE
Solicitation procedures
Only one sourceSSS
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
75N95020Q00327
Solicitation date
Sep 15, 2020
Notices

Contract details

Subcontracting plan
Plan not requiredB
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 22, 2020Base obligation at award: $55,800
Latest action
Sep 15, 2025 — Funding onlyModification P00001; obligation change -$48,800; funding only: changes obligations, not scope
Latest funding action
Sep 15, 2025 — Funding onlyModification P00001; obligation change -$48,800; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Funding only1
2 actions recorded, Sep 22, 2020 to Sep 15, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$48,800
Latest action: change in base and all options
-$48,800

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business not incorporated in the U.S.D
Country of product or service origin
United kingdomGBR
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Purchase orderB
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N950
Transactions recorded under this award key
2

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N950
Treasury accounts
  • 075-2020/2020-0893-000
Object classes
  • 25.6: Medical care
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression